TRAW logo
TRAW NASDAQ US

Traws Pharma, Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO Jul 2013
$1.64
▼ $-0.02 (-1.20%)
Vol 86K
4
Quality Score
fail
Mkt Cap
$9.0M
ROE
257.1%
Margin
-633.8%
D/E
0.00
Beta
1.71
52W
$1–$15

Wall Street Consensus

7 analysts · Apr 2026
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Similar Stocks

LPCN
Lipocine Inc
$44.6M
HIND
Vyome Holdings Inc
$19.4M
CURX
Curanex Pharmaceuticals Inc
$9.4M
JUNS
Jupiter Neurosciences Inc
$35.1M
BFRI
Biofrontera Inc
$6.6M
CVKD
Cadrenal Therapeutics Inc
$15.9M
CALC
CalciMedica Inc
$95.0M
RVPH
Reviva Pharmaceuticals Holdings Inc
$32.1M

Earnings

Beat rate: 75.0%
Next Report May 13, 2026
EPS Estimate: $-0.79
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.79 — —
Dec 2024 $-9.74 $95.66 +$105.40
Sep 2024 $-6.25 $-8.81 $-2.56
Dec 2023 $-6.46 $-4.75 +$1.71

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) 281.6% -1680.3% 288.5% 288.5% 288.5% 257.1%
P/E (TTM) — — — — — —
Net Margin -33.7% -61696.0% -613.9% -613.9% -613.9% -633.8%
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 2.04 1.81 2.09 2.09 2.09 1.22

Key Ratios

ROA (TTM)
-77.1%
P/S (TTM)
3.11
EPS (TTM)
$-7.44
Rev Growth 3Y
0.0%
52W High
$15.00
52W Low
$0.97
$0.97 52-Week Range $15.00

How does TRAW compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

TRAW AARD ACB ACRS ADIL

TRAW valuation vs Pharmaceuticals peers

P/E ratio
—
▼ 0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
3.1
▼ 37% below peers (5.0)
vs Peers
vs Industry
Undervalued
P/B ratio
—
▼ 0% below peers (2.1)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (2.0%)
vs Peers
vs Industry
Low yield

TRAW profitability vs Pharmaceuticals peers

ROE
257.1%
▲ 574% above peers (-54.3%)
vs Peers
vs Industry
Top tier
Net margin
-633.8%
▼ 1238% below peers (-47.4%)
vs Peers
vs Industry
Weak
Gross margin
—
▼ 0% below peers (68.3%)
vs Peers
vs Industry
In line
ROA
-77.1%
▼ 106% below peers (-37.4%)
vs Peers
vs Industry
Weak

TRAW financial health vs Pharmaceuticals peers

D/E ratio
0.0
▼ 100% below peers (1.5)
vs Peers
vs Industry
Low debt
Current ratio
1.2
▼ 64% below peers (3.4)
vs Peers
vs Industry
Low liquidity
Beta
1.7
▲ 82% above peers (0.9)
vs Peers
vs Industry
More volatile

TRAW fundamentals radar

TRAW Peer median Industry

TRAW profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

TRAW vs peers: key metrics

Latest News

‘A national scandal’: trawlers scour seabeds of supposedly protected UK waters
The Guardian · Mar 31